JULIUS DISTRIBUTION UK LTD
Company number 13816169 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JULIUS DISTRIBUTION UK LTD - Analysis Report
Company Number: 13816169
Analysis Date: 2025-07-29 15:40 UTC
Financial Health Assessment of JULIUS DISTRIBUTION UK LTD
1. Financial Health Score: B
Explanation:
JULIUS DISTRIBUTION UK LTD shows solid financial stability with positive net assets and healthy working capital. The company is maintaining growth and managing liabilities reasonably well given its micro-entity status and recent incorporation. However, the relatively high level of long-term liabilities compared to net assets signals a cautious watch is needed to ensure debt obligations remain sustainable.
2. Key Vital Signs (Core Financial Metrics):
| Metric | 2023 Value | Interpretation |
|---|---|---|
| Fixed Assets | £87,311 | Indicates investment in long-term resources, stable growth. |
| Current Assets | £318,775 | Good liquidity; sufficient short-term assets to cover needs. |
| Current Liabilities | £57,194 | Manageable short-term obligations; positive net working capital of £261,581. |
| Net Current Assets | £261,581 | Strong "cash flow pulse" indicating healthy short-term financial position. |
| Long-term Liabilities | £294,165 | Significant debt load; needs monitoring to avoid distress. |
| Net Assets (Equity) | £42,953 | Positive equity shows net value after debts; indicates solvency. |
| Shareholders Funds | £42,953 | Mirrors net assets; shareholders’ stake in company value. |
| Employee Count | 10 (2023) | Growth from 4 in 2022 suggests expanding operations. |
3. Diagnosis (What the Financial Data Reveals):
- Healthy Cash Flow and Liquidity: The company has a robust net current assets figure (£261,581), acting like a strong heartbeat that supports day-to-day operations without undue strain.
- Growth Phase: Employee numbers increased from 4 to 10 in one year, reflecting business expansion and possibly increased sales or service capacity.
- Leverage Concerns: The long-term liabilities (£294,165) are quite high relative to net assets (£42,953), indicating the company has taken on considerable debt or obligations which could pose risks if not managed prudently.
- Profitability & Reserves: As a micro-entity, detailed profit and loss data are limited, but net asset growth (£39,082 to £42,953) suggests retained earnings or capital injections are helping build net worth.
- Compliance and Governance: The company is up-to-date on filings, with no overdue accounts or returns, indicating sound administrative health and regulatory compliance.
4. Recommendations (Actions to Improve Financial Wellness):
- Debt Management: Strategically plan to reduce or refinance long-term liabilities to ease financial burden. Consider negotiating better terms or consolidating debt to improve balance sheet resilience.
- Strengthen Capital Base: Explore opportunities to increase shareholders’ funds either through retained profits or new capital to provide a larger equity buffer against liabilities.
- Cash Flow Monitoring: Maintain vigilant tracking of working capital to ensure the "cash flow pulse" remains strong, especially as the company grows and takes on more employees.
- Growth Planning: Continue investing in fixed assets prudently to support expansion, but avoid overextension that may strain liquidity.
- Financial Forecasting: Implement regular forecasting and scenario planning to anticipate financial stress symptoms early and take corrective action.
- Governance & Risk Management: Keep filing deadlines and governance practices current, and consider formalizing risk assessments to pre-empt business challenges.
Medical Analogy Summary:
JULIUS DISTRIBUTION UK LTD’s financial vital signs show a generally healthy condition with a strong pulse of working capital and growth vitality. However, the sizable long-term debt is a symptom of potential cardiovascular strain on its financial system. With careful debt management and capital strengthening, the company’s prognosis remains positive for sustained business health and growth.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.